Exosome Therapy
You may see exosomes advertised in skin treatments, hair treatments and regenerative medicine packages. To understand an offer, look beyond the word “exosomes”: the source, preparation, intended use and way the product is given all matter.
This page explains common exosome claims, the evidence needed to assess them and the questions to ask a provider. Evidence is specific to a product and use; an encouraging study does not establish that every product sold under the same name will have the same benefits.
Start here
Why are you looking into exosomes?
What Is Actually in the Vial
Exosomes are a type of extracellular vesicle: tiny membrane-bound particles released by cells. They can carry proteins, lipids and genetic material involved in communication between cells. Not every extracellular vesicle is an exosome, and a product marketed as “exosomes” may contain a mixture of vesicles and other material.
The big circle is a cell. The tiny dot beside it is an exosome.
Even this drawing is generous to the exosome. In real life an exosome is far smaller than a cell, too small to see with an ordinary microscope. Unlike a living cell, it cannot divide or develop into tissue. Researchers study how its contents interact with other cells.
| Stem cells | Exosomes | |
|---|---|---|
| What they are | Living cells | Particles released by cells |
| Alive | Yes | No |
| Where they come from | Your body or a donor | Usually cells grown in a lab, often from donor tissue |
| Common forms sold | Injections and drips | Injections, drips, inhaled sprays, and serums applied to the skin |
| Agreed standard dose | Varies by product | No single dose applies across products and uses |
A skin serum that contains exosomes and an injection into your joint or bloodstream are very different things. The risks differ by product, dose and route. Injections and drips introduce material into the body, while use on intact skin differs from use after microneedling or laser treatment. A topical product should not be assumed suitable for injection.
Common Exosome Claims: What to Check
The questions below separate regulatory status, safety, product quality and clinical benefit. An unanswered question means more information is needed; it does not by itself prove that a treatment works or does not work.
“Exosomes are FDA approved”
What to know: The FDA states that there are currently no FDA-approved exosome products. This describes U.S. approval status, rather than the rules in every country. A clinic license, facility registration or trial listing does not by itself establish approval of a product for a particular use.
Ask the provider: What is the exact product name, and can you show the regulator’s authorization for this product, intended use and route in the country where it will be given?
“No cells means no risk”
What to know: Not containing living cells does not make a product risk-free. Manufacturing quality, contaminants, ingredients and the route of administration can affect safety. The FDA has reported serious adverse events associated with unapproved products marketed as containing exosomes.
Ask the provider: What product-specific safety data are available, what batch testing was performed, and who will manage and report a reaction?
“Exosomes are just a stronger form of stem cell therapy”
What to know: Exosome products and living-cell products differ in composition and biological activity. Calling one “stronger” does not explain its clinical benefit. Evidence for a cell treatment cannot automatically be applied to a separate exosome preparation.
Ask the provider: Are there comparative human studies of this specific product and the alternative being discussed for my condition?
“They regrow hair, cartilage or nerves”
What to know: These are separate outcomes that need separate evidence. Human research is emerging in hair and skin applications, but results from a particular formulation cannot establish benefits for other products, cartilage or nerves. A change in hair density also does not by itself demonstrate that lost follicles were recreated.
Ask the provider: Which human studies match this product, my condition and the proposed route, and what did they actually measure over what follow-up period?
“They reverse aging”
What to know: Changes in skin appearance and reversal of biological aging are different claims. A study measuring wrinkles or skin texture cannot by itself establish whole-body rejuvenation, longer life or reversal of age-related disease.
Ask the provider: What does “reverse aging” mean here, which outcome was measured, and is there controlled human evidence for that outcome with this product?
“They treat long COVID, autism or other serious conditions”
What to know: Each condition requires its own clinical assessment and supporting human evidence. A proposed mechanism or results in another condition do not establish a clinical benefit for these uses. An offer should explain the investigational status, uncertainties and alternatives without promising improvement.
Ask the provider: What controlled human evidence supports this exact use, is it part of an authorized study, and how will my existing care and follow-up be coordinated?
“Our exosomes are lab-tested and standardized”
What to know: Research guidelines such as MISEV2023 describe ways to characterize extracellular vesicles. However, “lab-tested” alone does not identify which tests were performed or establish clinical effectiveness. Product identity, purity, dose measurements and batch consistency need documentation.
Ask the provider: Can I see a batch-specific report, the tests and acceptance criteria used, and an explanation of what the results do and do not confirm?
“Exosomes are a promising area of research”
What to know: Researchers are investigating extracellular vesicles for biological effects and medicine delivery. Research interest is a reason to study a product; clinical usefulness still depends on evidence for its specific preparation, indication, dose and route.
Ask the provider: What stage has this particular product reached, and are published human results available beyond laboratory or animal findings?
How Exosome Products Are Made
- Cells are grown in a lab, often from donated umbilical cord, placenta, fat or bone marrow tissue.
- The liquid around the cells is collected. This is where the cells release their exosomes.
- The exosomes are separated and concentrated using filters or high-speed spinning.
- The product is packaged and may be frozen or freeze-dried. Ask which quality tests are performed and how storage is validated.
- It is given by injection, drip, spray or applied to the skin, depending on the product.
Every step is a chance for the product to vary, which is why two exosome products with the same name may not contain the same thing.
Potential Risks and Remaining Questions
Contamination
Bacteria or other material from poor manufacturing, which can cause serious infection.
Reactions
Fever, allergic or immune reactions to donor-derived material.
The unknown
Long-term effects of injecting exosomes into people have not been studied enough to know.
Seek medical help straight away if you develop a fever, chills, rash, breathing difficulty, or redness and swelling where you were treated.
Before You Say Yes
If a provider offers you exosomes, request clear written answers to these questions. Review the answers with a qualified clinician independent of the provider when possible.
- ☐ What cells were the exosomes made from, and how was the donor tissue screened?
- ☐ Who manufactured the product, and can I see its test results for sterility and purity?
- ☐ What is its regulatory status in the treatment country, and what documentation confirms authorization for this use?
- ☐ How will it be given, and why that way for my problem?
- ☐ What evidence in people supports it for my condition?
- ☐ Is this part of a registered clinical trial, and what regulatory and ethics approvals apply?
- ☐ What happens if I have a reaction, and who looks after me?
To compare approaches, discuss condition-specific evidence and established treatment options with your doctor. You can also read our stem cell therapy and PRP therapy pages, or explore study listings on ClinicalTrials.gov. A trial listing is not proof of regulatory approval, safety or effectiveness.
Questions Patients Ask Us
Are exosome skin serums the same as exosome injections?
No. Products applied to intact skin, products used after procedures that disrupt the skin barrier, and injected products involve different exposure and safety questions. Cosmetic marketing does not establish suitability for injection or approval to treat a disease. Ask about the exact formulation and intended route.
Why is there interest in exosome products?
Their role in cell communication has attracted research and commercial interest. Some preparations may offer different manufacturing and storage possibilities from living-cell products, but stability and quality must be demonstrated for each formulation. Advertising does not establish clinical benefit.
How could exosome research lead to established treatments?
Progress depends on well-designed human studies, consistent manufacturing, safety monitoring and the relevant regulatory assessment. Ask whether the specific product and use being offered are investigational or authorized locally. Findings from one preparation should not be generalized to all exosome products.
Not Sure About an Exosome Offer
A PlacidWay patient coordinator can help you request product information and prepare questions for a qualified clinician before you decide.
Request InformationReferences
- U.S. Food and Drug Administration, Public Safety Notification on Exosome Products
- U.S. Food and Drug Administration, Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes
- International Society for Extracellular Vesicles
- International Society for Stem Cell Research, Patient Resources
- ClinicalTrials.gov, Registered Studies of Exosomes
- ISEV, MISEV2023: Minimal Information for Studies of Extracellular Vesicles
- Human hair-loss research: 12-week randomized trial of a topical formulation containing milk-derived vesicles and other active ingredients (2026); results apply to the complete formulation
This page is for general information and is not medical advice. Consult a qualified doctor before considering any exosome product.
Who stands behind this article
Health content should never be anonymous. Here are the people who wrote and checked it, with credentials you can verify independently.
Usama
Patient Care Writer
This author specializes in global healthcare trends and medical education. By focusing on evidence-based practices and a patient-first approach, they provide accessible resources to help readers understand their international treatment options with clarity.
Stem Cell Therapy, Longevity & Regenerative Medicine Specialist
Dr. Alejandro Fernando is a Mexico City-based physician and medical content reviewer focused on stem cell therapy, regenerative medicine, cellular therapy and longevity medicine. His reviewer profile lists medical and postgraduate training related to regenerative medicine, cellular therapy and stem cell biology.
How this article was checked
Table of Contents
